Blog
Infrastructure Stock Up 67% This Past Year Just Drew a New $6 Million Investment
Candelo Capital Management disclosed a new position in Granite Construction (NYSE:GVA) on February 17, 2026, acquiring 49,088 shares in an estimated $5.66 million trade based on quarterly average
SPXL vs. TQQQ: Is S&P 500 Stability or Tech-Focused Growth the Better Buy for Leveraged ETF Investors?
The ProShares - UltraPro QQQ (NASDAQ:TQQQ) and the Direxion Daily S&P 500 Bull 3X ETF (NYSEMKT:SPXL) are both designed for aggressive traders seeking amplified daily moves, but their underlying
Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year
On February 17, 2026, Solas Capital Management disclosed a new position in Primo Brands Corporation (NYSE:PRMB), acquiring 460,619 shares in the fourth quarter.
Solas Capital Management disclosed
Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue
On February 17, 2026, Solas Capital Management disclosed a new position in Euronet Worldwide (NASDAQ:EEFT), acquiring 73,494 shares in the fourth quarter. The shares were worth $5.59 million at
Is Signet Jewelers Seriously Undervalued?
Signet Jewelers (NYSE: SIG) owns brands you see in malls around the country, including Kay, Zales, and Jarred, among others. The stock has been volatile in recent years, rising and falling in
Target Is Cutting Prices on 3,000 Items As Inflation Drags Down Consumer Spending. Is Inflation Target Stock's Biggest Pain Point Right Now?
Walmart (NASDAQ: WMT) is eating Target's (NYSE: TGT) lunch right now. To put a number on that, Walmart's same-store sales rose 4.6% in the most recent quarter while Target's fell 2.5%. Target is
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment
On February 17, 2026, Parkman Healthcare Partners disclosed a new position in EyePoint (NASDAQ:EYPT), acquiring 1,088,033 shares in the fourth quarter.
According to a Securities and Exchange
2 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade
While artificial intelligence (AI) has gained a lot of investor attention, the technology appears to still be in the very early innings. As such, it should be a growth driver for quite some time
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement
On February 17, 2026, Parkman Healthcare Partners disclosed a new position in Masimo Corporation (NASDAQ:MASI), acquiring 200,000 shares in the fourth quarter worth an estimated $26.01 million at
This Community Bank With $9 Billion in Assets Just Drew a $2.5 Million Investor Buy
On February 17, 2026, Elizabeth Park Capital Advisors disclosed buying 70,151 shares of Origin Bancorp (NYSE:OBK), an estimated $2.51 million trade based on quarterly average pricing.
According to
The Most Overlooked Artificial Intelligence (AI) Stocks in the "Magnificent Seven" for 2026
The "Magnificent Seven" is a group of stocks that are often pointed to as market leaders. Currently, all seven are among the world's top-10 largest companies. That's an impressive spot to be in, and
Regional Bank Stock Up 14% in a Year as Investor Sells $2.6 Million in Shares
On February 17, 2026, Elizabeth Park Capital Advisors disclosed a sale of 23,200 shares of UMB Financial (NASDAQ:UMBF), an estimated $2.63 million trade based on quarterly average pricing.
According
Billionaires David Tepper and Michael Platt Sold Nvidia Shares and Bought This AI Stock That's Climbed 40,000% Since its IPO.
There are many paths to a billion-dollar portfolio, meaning billionaires don't always agree when it comes to investment opportunities. Even if it's clear that the area of artificial intelligence
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares
On February 17, 2026, OrbiMed Advisors reported selling 143,304 shares of Sionna Therapeutics (NASDAQ:SION), an estimated $5.43 million trade based on quarterly average pricing.
According to a
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share
On February 17, 2026, OrbiMed Advisors disclosed a buy of 556,273 shares of RAPT, with an estimated transaction value of $17.28 million based on quarterly average pricing.
According to a Securities
Offshore Driller With $7.5 Billion Backlog Sees $6 Million Investor Trim Amid Staggering Stock Surge
Kerrisdale Advisers disclosed in a February 17, 2026, SEC filing that it reduced its stake in Noble Corporation plc (NYSE:NE), selling 204,364 shares in a trade estimated at $6.04 million based on
Telecom Stock Up 25% Over the Past Year Draws $21 Million Bet From Hedge Fund
Kerrisdale Advisers initiated a new position in Telephone and Data Systems (NYSE:TDS), acquiring 506,067 shares in the fourth quarter, valued at $20.75 million based on quarter-end pricing
Best Artificial Intelligence (AI) Stock to Buy Now: Nvidia vs. Palantir
Nvidia (NASDAQ: NVDA) and Palantir (NASDAQ: PLTR) have been top artificial intelligence (AI) investment options over the past few years. These two have partnered together to optimize their offerings
Fidelity (FDVV) vs. ProShares (NOBL): Which Dividend ETF Reigns Supreme?
The key differences between ProShares S&P 500 Dividend Aristocrats® ETF (NYSEMKT:NOBL) and Fidelity High Dividend ETF (NYSEMKT:FDVV) come down to cost, yield, recent performance, and sector
Should You Buy Micron Before Earnings? Here's the 1 Thing That Matters.
Micron Technology (NASDAQ: MU) will report its fiscal second-quarter 2026 earnings on March 18. Wall Street expects average revenue of about $19.1 billion, up roughly 137.4% year over year, and
Is a Sub-6% Mortgage Rate Enough to Make Buying in Retirement Worth It?
Thirty-year mortgage rates recently dropped below 6%, which raises the question of whether a sub-6% rate is low enough to make buying a home a smart move in retirement. The reality is that there are
Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy?
According to a U.S. Securities and Exchange Commission (SEC) filing dated February 17, 2026, Boone Capital Management established a new position in HealthEquity by purchasing 212,856 shares. The
Boston Omaha Looks Cheap on Paper, but Weak Management Could Keep It a Value Trap
Is a wide discount to asset value enough to justify owning a troubled stock? See how differing views on governance, capital allocation, and catalysts shape the debate around Boston Omaha's (NYSE:
Top 2 Index Funds to Beat the S&P 500 Over the Next 5 Years, According to Wall Street
Up until 2026, the S&P 500 (SNPINDEX: ^GSPC) spent years as the class of the U.S. equity market. Powered by the "Magnificent Seven" stocks and the artificial intelligence (AI) boom, large caps were
What Drove Shiba Inu's Double-Digit Move Higher This Past Week?
Shiba Inu (CRYPTO: SHIB) is among the most impactful movers in this week's cryptocurrency market. The world's second-largest meme coin surged 10.6% over the past seven days (as of 12:45 p.m. ET